공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

세계의 의약품용 임상시험약 공급과 물류 시장 : 단계별, 부문별, 치료 분야별 시장 조사, 예측(-2025년), COVID-19의 누적 영향

Clinical Trial Supply & Logistics for Pharmaceutical Market Research Report by Phase, by Sector, by Therapeutic Area, by Region - Global Forecast to 2025 - Cumulative Impact of COVID-19

리서치사 360iResearch LLP
발행일 2021년 06월 상품 코드 1002734
페이지 정보 영문 192 Pages
가격
US $ 3,949 ₩ 4,451,000 Online Access (Single User License - 1 Year)
US $ 4,949 ₩ 5,579,000 PDF (Single User License) + Excel
US $ 5,949 ₩ 6,706,000 PDF (1-5 User License) + Excel
US $ 7,949 ₩ 8,960,000 PDF (Site License) + Excel
US $ 9,949 ₩ 11,215,000 PDF (Enterprise License) + Excel


세계의 의약품용 임상시험약 공급과 물류 시장 : 단계별, 부문별, 치료 분야별 시장 조사, 예측(-2025년), COVID-19의 누적 영향 Clinical Trial Supply & Logistics for Pharmaceutical Market Research Report by Phase, by Sector, by Therapeutic Area, by Region - Global Forecast to 2025 - Cumulative Impact of COVID-19
발행일 : 2021년 06월 페이지 정보 : 영문 192 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 의약품용 임상시험약 공급과 물류 시장 규모는 2020년 182억 1,374만 달러에서 2025년 말까지 263억 6,459만 달러로 성장할 것으로 예상됩니다.

시장 세분화와 커버리지:

이 조사 보고서는 세계의 의약품용 임상시험약 공급과 물류 시장을 분류하고, 매출을 예측하고, 다음 각 서브 마켓의 동향을 분석합니다.

단계별로 시장은 BA/BE 연구, 단계 I, 단계 II, 단계 III 및 단계 IV에 걸쳐 조사되었습니다. 단계 III은 2020년에 의약품용 임상시험약 공급과 물류 시장에서 최대 규모를 차지하고, 예측기간 중 가장 빠른 CAGR로 성장할 것으로 예상됩니다.

단계 III은 예측기간 중 가장 높은 성장을 이룰 것으로 예측됩니다.

부문별로 시장은 임상시험 물류와 유통, 임상시험 제조 서비스, 임상시험 공급망 관리에 걸쳐 조사되었습니다. 임상시험 공급망 관리는 2020년에 의약품용 임상시험약 공급과 물류 시장에서 최대 규모를 차지했습니다. 한편 임상시험 물류와 유통은 예측기간 중 가장 빠른 CAGR로 성장할 것으로 예상됩니다.

임상시험 물류와 유통은 예측기간 중 가장 높은 성장을 이룰 것으로 예측됩니다.

치료 분야별로 시장은 혈액질환, 소화기계 질환, 감염성 및 면역계 질환, 신경 및 정신장애, 종양학에 걸쳐 조사되었습니다. 감염성 및 면역계 질환은 2020년에 의약품용 임상시험약 공급과 물류 시장에서 최대 규모를 기록하고, 예측기간 중 가장 빠른 CAGR로 성장할 것으로 예상됩니다.

감염성 및 면역계 질환은 예측기간 중 가장 높은 성장을 목격할 것으로 예측됩니다.

지역별로 시장은 아메리카, 아시아태평양 및 유럽·중동·아프리카로 분류되어 조사되었습니다. 아메리카는 아르헨티나, 브라질, 캐나다, 멕시코 및 미국으로, 아시아태평양은 호주, 중국, 인도, 인도네시아, 일본, 말레이시아, 필리핀, 한국, 태국으로, 유럽·중동·아프리카는 프랑스, 독일, 이탈리아, 네덜란드, 카타르, 러시아, 사우디아라비아, 남아프리카공화국, 스페인, 아랍에미리트 및 영국으로 조사되었습니다. 아메리카는 2020년에 의약품용 임상시험약 공급과 물류 시장에서 최대 규모를 차지했습니다. 한편 아시아태평양은 예측기간 중 가장 빠른 CAGR로 성장할 것으로 예상됩니다.

아시아태평양은 예측기간 중 최고의 성장을 목격할 것으로 예측됩니다.

기업 유저빌리티 개요:

이 보고서는 Almac Group, Bilcare Limited, Biocair International Limited, Catalent, Inc., Clinigen Group PLC, DHL International GmbH by Deutsche Post AG, Eurofins Scientific SE, FedEx Corporation, Infosys Limited, KLIFO A/S, Lonza Group, Marken, Metrics Contract Services by Mayne Pharma group, Movianto, N-Side, Parexel International Corporation, PRA Health Sciences, Inc., Seveillar Clinical Trial Supplies Pvt. Ltd., SIRO Clinpharm Private Limited, Thermo Fisher Scientific, Inc., UDG Healthcare PLC, World Courier Management Inc.등 세계 시장의 주요 벤더에 의한 최근의 중요한 진전과 혁신 프로파일을 깊게 탐구하고 있습니다.

COVID-19의 누적 영향:

COVID-19는 거의 모든 업계에 영향을 미친 전례 없는 세계적인 공중위생상 긴급사태이기 때문에 예측기간 중 업계의 성장에 장기적인 영향을 미칠 것으로 예측됩니다. 우리가 진행중인 조사는 조사 프레임워크를 증폭하고, 기초가 되는 COVID-19의 문제와 향후 잠재적 방향을 확실히 포함시키고 있습니다. 조사는 소비자의 행동과 수요 변화, 구입 패턴, 공급망 재라우팅, 현재 시장 힘의 역학 및 정부의 중요한 개입을 고려한 COVID-19에 관한 인사이트를 제공합니다. 갱신된 조사는 시장에 대한 COVID-19의 영향을 고려하고, 인사이트, 분석, 추정 및 예측을 제공합니다.

세계의 의약품용 임상시험약 공급과 물류(Clinical Trial Supply & Logistics for Pharmaceutical) 시장을 조사했으며, 시장 개요, 시장 성장 촉진요인 및 저해요인 분석, 시장 기회, COVID-19의 영향, 단계·부문·치료 분야·지역별 시장 규모 추정과 예측, 경쟁 상황, 주요 기업 개요 등 체계적인 정보를 제공합니다.

목차

제1장 서문

  • 조사 목적
  • 시장 세분화와 커버리지
  • 조사 대상 연도
  • 통화와 가격
  • 언어
  • 제한
  • 이해관계자

제2장 조사 방법

  • 조사 과정
    • 정의 : 조사 목적
    • 결정 : 조사 디자인
    • 준비 : 조사 기기
    • 수집 : 데이터 소스
    • 분석 : 데이터 해석
    • 책정 : 데이터 검증
    • 공개 : 조사 보고서
    • 반복 : 보고서 갱신
  • 조사 실행
    • 개시 : 조사 과정
    • 계획 : 조사 계획 작성
    • 실행 : 조사 실시
    • 검증 : 발견과 분석
    • 출판물 : 조사 보고
  • 조사 성과

제3장 주요 요약

  • 시장 전망
  • 부문 전망
  • 단계 전망
  • 치료 분야 전망
  • 지역 전망
  • 경쟁사 전망

제4장 시장 개요

  • COVID-19의 누적 영향

제5장 시장 인사이트

  • 시장 역학
    • 성장 촉진요인
    • 성장 억제요인
    • 시장 기회
    • 과제
  • Porter's Five Forces 분석
    • 신규 참여업체의 위협
    • 대체품의 위협
    • 고객의 협상력
    • 공급 기업의 협상력
    • 업계의 경쟁

제6장 단계별

  • BA/BE 연구
  • 단계 I
  • 단계 II
  • 단계 III
  • 단계 IV

제7장 부문별

  • 임상시험 물류와 유통
  • 임상시험 제조 서비스
  • 임상시험 공급망 관리

제8장 치료 분야별

  • 혈액질환
  • 소화기계
  • 감염성 및 면역계
  • 신경장애 및 정신장애
  • 종양학

제9장 아메리카

  • 아르헨티나
  • 브라질
  • 캐나다
  • 멕시코
  • 미국

제10장 아시아태평양

  • 호주
  • 중국
  • 인도
  • 인도네시아
  • 일본
  • 말레이시아
  • 필리핀
  • 한국
  • 태국

제11장 유럽, 중동 및 아프리카

  • 프랑스
  • 독일
  • 이탈리아
  • 네덜란드
  • 카타르
  • 러시아
  • 사우디아라비아
  • 남아프리카공화국
  • 스페인
  • 아랍에미리트
  • 영국

제12장 경쟁 상황

  • FPNV 포지셔닝 매트릭스
    • 상한
    • 사업 전략
    • 제품 만족도
  • 시장 순위 분석
  • 시장 점유율 분석
  • 경쟁 시나리오
    • 합병과 인수
    • 계약, 협업 및 파트너십
    • 신제품 발매와 강화
    • 투자와 자금 조달
    • 상, 표창, 확대

제13장 기업 유저빌리티 개요

  • Almac Group
  • Bilcare Limited
  • Biocair International Limited
  • Catalent, Inc.
  • Clinigen Group PLC
  • DHL International GmbH by Deutsche Post AG
  • Eurofins Scientific SE
  • FedEx Corporation
  • Infosys Limited
  • KLIFO A/S
  • Lonza Group
  • Marken
  • Metrics Contract Services by Mayne Pharma group
  • Movianto
  • N-Side
  • Parexel International Corporation
  • PRA Health Sciences, Inc.
  • Seveillar Clinical Trial Supplies Pvt. Ltd.
  • SIRO Clinpharm Private Limited
  • Thermo Fisher Scientific, Inc.
  • UDG Healthcare PLC
  • World Courier Management Inc.

제14장 부록

  • 논의 가이드
  • 라이선스와 가격
KSM 21.05.21

LIST OF FIGURES

  • FIGURE 1. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2020 VS 2025 (USD MILLION)
  • FIGURE 2. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2020 (USD MILLION)
  • FIGURE 3. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2020 (USD MILLION)
  • FIGURE 4. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2020 (USD MILLION)
  • FIGURE 5. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
  • FIGURE 6. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET: MARKET DYNAMICS
  • FIGURE 7. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 8. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2020 VS 2025 (%)
  • FIGURE 9. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2020 VS 2025 (USD MILLION)
  • FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2025
  • FIGURE 11. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY BA/BE STUDIES, 2018-2025 (USD MILLION)
  • FIGURE 12. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY BA/BE STUDIES, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 13. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE I, 2018-2025 (USD MILLION)
  • FIGURE 14. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE I, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 15. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE II, 2018-2025 (USD MILLION)
  • FIGURE 16. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE II, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 17. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE III, 2018-2025 (USD MILLION)
  • FIGURE 18. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE III, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 19. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE IV, 2018-2025 (USD MILLION)
  • FIGURE 20. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE IV, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 21. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2020 VS 2025 (%)
  • FIGURE 22. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2020 VS 2025 (USD MILLION)
  • FIGURE 23. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2025
  • FIGURE 24. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY CLINICAL TRIAL LOGISTICS AND DISTRIBUTIONS, 2018-2025 (USD MILLION)
  • FIGURE 25. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY CLINICAL TRIAL LOGISTICS AND DISTRIBUTIONS, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 26. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY CLINICAL TRIAL MANUFACTURING SERVICES, 2018-2025 (USD MILLION)
  • FIGURE 27. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY CLINICAL TRIAL MANUFACTURING SERVICES, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 28. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY CLINICAL TRIAL SUPPLY CHAIN MANAGEMENT, 2018-2025 (USD MILLION)
  • FIGURE 29. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY CLINICAL TRIAL SUPPLY CHAIN MANAGEMENT, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 30. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2020 VS 2025 (%)
  • FIGURE 31. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2020 VS 2025 (USD MILLION)
  • FIGURE 32. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2025
  • FIGURE 33. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY BLOOD DISORDERS, 2018-2025 (USD MILLION)
  • FIGURE 34. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY BLOOD DISORDERS, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 35. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY DIGESTIVE SYSTEM DISEASES, 2018-2025 (USD MILLION)
  • FIGURE 36. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY DIGESTIVE SYSTEM DISEASES, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 37. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY INFECTIOUS AND IMMUNE SYSTEM DISEASES, 2018-2025 (USD MILLION)
  • FIGURE 38. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY INFECTIOUS AND IMMUNE SYSTEM DISEASES, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 39. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY NEUROLOGICAL AND MENTAL DISORDERS, 2018-2025 (USD MILLION)
  • FIGURE 40. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY NEUROLOGICAL AND MENTAL DISORDERS, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 41. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ONCOLOGY, 2018-2025 (USD MILLION)
  • FIGURE 42. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ONCOLOGY, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 43. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
  • FIGURE 44. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 45. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY GEOGRAPHY, 2025
  • FIGURE 46. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 47. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 48. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 49. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 50. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 51. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
  • FIGURE 52. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 53. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY GEOGRAPHY, 2025
  • FIGURE 54. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 55. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 56. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 57. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 58. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 59. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 60. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 61. THAILAND CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 62. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
  • FIGURE 63. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 64. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY GEOGRAPHY, 2025
  • FIGURE 65. FRANCE CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 66. GERMANY CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 67. ITALY CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 68. NETHERLANDS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 69. QATAR CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 70. RUSSIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 71. SAUDI ARABIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 72. SOUTH AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 73. SPAIN CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 74. UNITED ARAB EMIRATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 75. UNITED KINGDOM CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 76. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET: FPNV POSITIONING MATRIX
  • FIGURE 77. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET: SHARE, BY QUADRANT, 2020
  • FIGURE 78. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 4. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY BA/BE STUDIES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 5. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE I, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 6. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE II, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 7. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE III, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 8. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE IV, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 9. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 10. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY CLINICAL TRIAL LOGISTICS AND DISTRIBUTIONS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 11. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY CLINICAL TRIAL MANUFACTURING SERVICES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 12. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY CLINICAL TRIAL SUPPLY CHAIN MANAGEMENT, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 13. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 14. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY BLOOD DISORDERS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 15. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY DIGESTIVE SYSTEM DISEASES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 16. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY INFECTIOUS AND IMMUNE SYSTEM DISEASES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 17. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY NEUROLOGICAL AND MENTAL DISORDERS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 18. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ONCOLOGY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 19. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 20. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 21. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 22. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 23. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 24. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 25. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 26. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 27. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 28. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 29. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 30. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 31. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 32. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 33. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 34. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 35. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 36. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 37. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 38. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 39. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 40. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 41. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 42. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 43. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 44. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 45. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 46. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 47. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 48. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 49. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 50. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 51. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 52. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 53. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 54. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 55. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 56. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 57. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 58. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 59. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 60. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 61. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 62. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 63. THAILAND CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 64. THAILAND CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 65. THAILAND CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 66. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 67. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 68. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 69. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 70. FRANCE CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 71. FRANCE CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 72. FRANCE CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 73. GERMANY CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 74. GERMANY CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 75. GERMANY CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 76. ITALY CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 77. ITALY CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 78. ITALY CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 79. NETHERLANDS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 80. NETHERLANDS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 81. NETHERLANDS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 82. QATAR CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 83. QATAR CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 84. QATAR CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 85. RUSSIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 86. RUSSIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 87. RUSSIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 88. SAUDI ARABIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 89. SAUDI ARABIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 90. SAUDI ARABIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 91. SOUTH AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 92. SOUTH AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 93. SOUTH AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 94. SPAIN CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 95. SPAIN CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 96. SPAIN CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 99. UNITED ARAB EMIRATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 100. UNITED KINGDOM CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 101. UNITED KINGDOM CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 102. UNITED KINGDOM CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 103. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET: SCORES
  • TABLE 104. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET: BUSINESS STRATEGY
  • TABLE 105. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET: PRODUCT SATISFACTION
  • TABLE 106. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET: RANKING
  • TABLE 107. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET: SHARE, BY QUADRANT, 2020
  • TABLE 108. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET: MERGER & ACQUISITION
  • TABLE 109. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 110. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 111. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET: INVESTMENT & FUNDING
  • TABLE 112. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 113. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET: LICENSE & PRICING
  • TABLE 114. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET: CONTACT DETAILS

The Global Clinical Trial Supply & Logistics for Pharmaceutical Market size was estimated at USD 18,213.74 Million in 2020 and expected to reach USD 19,607.86 Million in 2021, at a Compound Annual Growth Rate (CAGR) 7.67% to reach USD 26,364.59 Million by 2025.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2025 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Clinical Trial Supply & Logistics for Pharmaceutical to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Phase, the Clinical Trial Supply & Logistics for Pharmaceutical Market was studied across BA/BE Studies, Phase I, Phase II, Phase III, and Phase IV.

Based on Sector, the Clinical Trial Supply & Logistics for Pharmaceutical Market was studied across Clinical Trial Logistics and Distributions, Clinical Trial Manufacturing Services, and Clinical Trial Supply Chain Management.

Based on Therapeutic Area, the Clinical Trial Supply & Logistics for Pharmaceutical Market was studied across Blood Disorders, Digestive System Diseases, Infectious and Immune System Diseases, Neurological and Mental Disorders, and Oncology.

Based on Geography, the Clinical Trial Supply & Logistics for Pharmaceutical Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Clinical Trial Supply & Logistics for Pharmaceutical Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Clinical Trial Supply & Logistics for Pharmaceutical Market, including Almac Group, Bilcare Limited, Biocair International Limited, Catalent, Inc., Clinigen Group PLC, DHL International GmbH by Deutsche Post AG, Eurofins Scientific SE, FedEx Corporation, Infosys Limited, KLIFO A/S, Lonza Group, Marken, Metrics Contract Services by Mayne Pharma group, Movianto, N-Side, Parexel International Corporation, PRA Health Sciences, Inc., Seveillar Clinical Trial Supplies Pvt. Ltd., SIRO Clinpharm Private Limited, Thermo Fisher Scientific, Inc., UDG Healthcare PLC, and World Courier Management Inc..

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Clinical Trial Supply & Logistics for Pharmaceutical Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Clinical Trial Supply & Logistics for Pharmaceutical Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Clinical Trial Supply & Logistics for Pharmaceutical Market?
  • 4. What is the competitive strategic window for opportunities in the Global Clinical Trial Supply & Logistics for Pharmaceutical Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Clinical Trial Supply & Logistics for Pharmaceutical Market?
  • 6. What is the market share of the leading vendors in the Global Clinical Trial Supply & Logistics for Pharmaceutical Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Clinical Trial Supply & Logistics for Pharmaceutical Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. Sector Outlook
  • 3.4. Phase Outlook
  • 3.5. Therapeutic Area Outlook
  • 3.6. Geography Outlook
  • 3.7. Competitor Outlook

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing R&D Expenditure of Pharmaceutical and Biopharmaceutical Industry
      • 5.1.1.2. Increased Focus on Drug Development
      • 5.1.1.3. Globalization of Clinical Trials and Harmonization of Regulations
    • 5.1.2. Restraints
      • 5.1.2.1. Increased Cost of Drug Development and Clinical Trials
    • 5.1.3. Opportunities
      • 5.1.3.1. Outsourcing of Clinical Trial Activity
      • 5.1.3.2. Increased Focus on Generics and Biologics
      • 5.1.3.3. Regulatory Approvals in Emerging Markets
    • 5.1.4. Challenges
      • 5.1.4.1. Logistics Challenges across Nations
  • 5.2. Cumulative Impact of COVID-19
  • 5.3. Porters Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry

6. Clinical Trial Supply & Logistics for Pharmaceutical Market, by Phase

  • 6.1. Introduction
  • 6.2. BA/BE Studies
  • 6.3. Phase I
  • 6.4. Phase II
  • 6.5. Phase III
  • 6.6. Phase IV

7. Clinical Trial Supply & Logistics for Pharmaceutical Market, by Sector

  • 7.1. Introduction
  • 7.2. Clinical Trial Logistics and Distributions
  • 7.3. Clinical Trial Manufacturing Services
  • 7.4. Clinical Trial Supply Chain Management

8. Clinical Trial Supply & Logistics for Pharmaceutical Market, by Therapeutic Area

  • 8.1. Introduction
  • 8.2. Blood Disorders
  • 8.3. Digestive System Diseases
  • 8.4. Infectious and Immune System Diseases
  • 8.5. Neurological and Mental Disorders
  • 8.6. Oncology

9. Americas Clinical Trial Supply & Logistics for Pharmaceutical Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Clinical Trial Supply & Logistics for Pharmaceutical Market

  • 10.1. Introduction
  • 10.2. China
  • 10.3. India
  • 10.4. Indonesia
  • 10.5. Japan
  • 10.6. Malaysia
  • 10.7. Philippines
  • 10.8. South Korea
  • 10.9. Thailand

11. Europe, Middle East & Africa Clinical Trial Supply & Logistics for Pharmaceutical Market

  • 11.1. Introduction
  • 11.2. France
  • 11.3. Germany
  • 11.4. Italy
  • 11.5. Netherlands
  • 11.6. Qatar
  • 11.7. Russia
  • 11.8. Saudi Arabia
  • 11.9. South Africa
  • 11.10. Spain
  • 11.11. United Arab Emirates
  • 11.12. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
    • 12.1.1. Quadrants
    • 12.1.2. Business Strategy
    • 12.1.3. Product Satisfaction
  • 12.2. Market Ranking Analysis
  • 12.3. Market Share Analysis, By Quadrant
  • 12.4. Competitive Scenario
    • 12.4.1. Merger & Acquisition
    • 12.4.2. Agreement, Collaboration, & Partnership
    • 12.4.3. New Product Launch & Enhancement
    • 12.4.4. Investment & Funding
    • 12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles

  • 13.1. Almac Group
  • 13.2. Bilcare Limited
  • 13.3. Biocair International Limited
  • 13.4. Catalent, Inc.
  • 13.5. Clinigen Group PLC
  • 13.6. DHL International GmbH by Deutsche Post AG
  • 13.7. Eurofins Scientific SE
  • 13.8. FedEx Corporation
  • 13.9. Infosys Limited
  • 13.10. KLIFO A/S
  • 13.11. Lonza Group
  • 13.12. Marken
  • 13.13. Metrics Contract Services by Mayne Pharma group
  • 13.14. Movianto
  • 13.15. N-Side
  • 13.16. Parexel International Corporation
  • 13.17. PRA Health Sciences, Inc.
  • 13.18. Seveillar Clinical Trial Supplies Pvt. Ltd.
  • 13.19. SIRO Clinpharm Private Limited
  • 13.20. Thermo Fisher Scientific, Inc.
  • 13.21. UDG Healthcare PLC
  • 13.22. World Courier Management Inc.

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing
  • 14.3. Contact Details
Back to Top
전화 문의
F A Q